Boehringer Ingelheim

8. Boehringer Ingelheim

Total Ad Spend: $174.7 million
Television: $119.6 million
Magazine: $54.7 million
Other: $363,740

The private company put its mouth where its money is, so to speak, talking up the two drugs that are its best sellers.

In the spotlight


Spiriva, $89.8 million
Pradaxa, $80.4 million


 

Boehringer Ingelheim
Read more on

Suggested Articles

It’s been a rocky road for BMS’ immuno-oncology duo in previously untreated lung cancer, but a new addition to the regimen might hold the ticket.

Novartis’ Zolgensma launch has been anything but boring: First a record price, then a data scandal and now a manufacturing-related delay in Europe.

As CEO Paul Hudson focuses Sanofi's R&D program on immuno-oncology and gene therapies, Sanofi is readying a vaccine plant to make viral vectors.